Montpellier cohort | NAD | n = 40 | AD | n = 10 | |
Variable | Mean | SD | Mean | SD | P |
Age (years) | 69.3 | 12.1 | 75.7 | 10.1 | 0.1330 |
Sex (% male) | 67.5% | – | 20.0% | – | 0.0070* |
MMSE | 21.2 | 6.2 | 18.5 | 4.4 | 0.2112 |
E_Tau (pg/mL) | 260 | 182 | 715 | 304 | < 0.0001 |
E_pT181 (pg/mL) | 42.9 | 24.6 | 95.8 | 25.0 | < 0.0001 |
MS_pT181 (fmol/mL) | 23.8 | 13.2 | 60.2 | 27.7 | < 0.0001 |
MS_pT217 (fmol/mL) | 0.948 | 1.066 | 11.740 | 5.006 | < 0.0001 |
WUSTL cohort | Amyloid (−) | n = 51 | Amyloid (+) | n = 33 | |
Variable | Mean | SD | Mean | SD | P |
Age (years) | 62.7 | 14.3 | 67.0 | 16.3 | 0.2063 |
Sex (% male) | 39.2% | – | 57.6% | – | 0.1007* |
CDR-SB | 0.34 | 1.09 | 1.77 | 1.82 | 0.0004 |
%E4 | 17.7% | – | 66.7% | – | < 0.0001* |
PiB-PET | 0.046 | 0.047 | 0.670 | 0.293 | < 0.0001 |
E_pT181 (pg/mL) | 47.5 | 21.5 | 76.0 | 25.4 | < 0.0001 |
MS_pT181 (ng/mL) | 0.350 | 0.256 | 0.596 | 0.312 | < 0.0001 |
MS_pT217 (ng/mL) | 0.057 | 0.1121 | 0.202 | 0.126 | < 0.0001 |